SGR-6016

N/A

Report date: 2026/01/15 10:57:38
NME

Base Information

Drug NameSGR-6016
Drug Alias NameSGR-6016SGR6016
ClassificationSmall molecules
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammationMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSchrödinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrödinger Inc
Inactive CompaniesN/A
Active IndicationsInflammationMetabolic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A